*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Impact of Warning Letters on Indian and United States Based Pharmaceutical Industries: Cause and Effect Analysis

Author: MEGHANA JIJI JOHNSON, DR RAJU KAMARAJ
Abstract: Purpose: To identify the cause and effect of warning letters on Indian and United States based companies. For most of the firms, increase in warning letters is a matter of concern. This analysis will allow other organizations to recognize repeated findings and learn how to avoid such non-compliance. Methods: 109 warning letters were issued to the manufacturers in the year of 2018, 2019, and 2020 under office of manufacturing quality letters, from which 35 warning letters released to Indian and American companies were reviewed. Pareto analysis performed to determine the top 4 categories. Further review and Pareto analysis identified the cause of the observations under these categories. Results: While reviewing, a total of 365 observations were noticed in 35 warning letters, issued due to significant violation of current good manufacturing practices for finished pharmaceuticals or active pharmaceutical ingredients. Pareto analysis revealed that the top four issues were 87.95% of the total observations. These are related to poor quality system (40.27%, 147), poor production control (21.92%, 80), poor laboratory control (14.8%, 54), breach of data integrity (10.96%, 28). Hence, it is evident that in the past three years Indian and US companies received warning letters majorly due to poor quality system. Conclusion: This Analysis shows that the firms have to enhance the quality system, especially the corrective and preventive action management, adequate quality unit and investigation system. Thus, suggesting that the manufacturers should study these warning letters periodically to be vigilant and to introduce preventive measures for avoiding the incident within their company.
Keyword: Warning letter, Food and Drug Administration, Pareto Analysis, Import alert
DOI: https://doi.org/10.31838/ijpr/2021.13.02.341
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free